Endotoxin and cytokines in patients with gastrointestinal tract perforation
1992

Endotoxin and Cytokines in Patients with Gastrointestinal Tract Perforation

Sample size: 70 publication Evidence: moderate

Author Information

Author(s): S. Endo, K. Inada, Y. Inoue, T. Otsu, T. Kasai, Y. Kuwata, S. Hoshi, M. Yoshida

Primary Institution: Iwate Medical University

Hypothesis

The study investigates the relationship between plasma endotoxin and cytokine levels in patients with gastrointestinal tract perforation and their clinical outcomes.

Conclusion

The study found that the clinical outcome correlated more with tumor necrosis factor (TNF) levels than with endotoxin levels in patients with gastrointestinal perforation.

Supporting Evidence

  • Sepsis developed in 29 out of 70 patients with gastrointestinal perforation.
  • Eight patients with sepsis had endotoxin levels higher than 9.8 pg/ml.
  • TNF levels were significantly higher in septic patients compared to non-septic patients.

Takeaway

Doctors looked at blood from patients with stomach problems to see if certain substances could help predict how sick they would get. They found that one substance, TNF, was more important than another, endotoxin, in deciding how patients would do.

Methodology

Blood samples were collected from 70 patients with gastrointestinal perforation, and levels of endotoxin, TNF, and IL-6 were measured using specific assays.

Limitations

The study may not have accurately determined the relationship between endotoxin levels and clinical outcomes due to the limitations of previous detection methods.

Participant Demographics

Patients included 45 cases of gastroduodenal perforation, 12 cases of small bowel perforation, and 13 cases of colonic perforation.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication